Biofarm is 88% owned by regional investment funds SIF Muntenia (50.9%), SIF Banat Crisana (23%) and SIF Moldova (13.6%).
The company’s shares have increased by 4% since the start of 2018.
Biofarm has a market capitalization of RON300 million.
Romanian pharmaceutical producer Biofarm (BIO.RO) registered 12% higher sales revenue, of RON170 million, and 24% higher net profit, of RON36 million, in 2017. Its debts rose from RON42 million to RON46 million, according to its preliminary financial results for 2017 sent Wednesday to the Bucharest Stock Exchange.